Investigational therapy efzimfotase alfa shows promising Phase III results in rare bone disease
Efzimfotase alfa is an investigational enzyme replacement therapy designed to reduce injection volume
Efzimfotase alfa is an investigational enzyme replacement therapy designed to reduce injection volume
Zyrifa is indicated for patients with bone metastases stemming from a wide range of solid tumors
The cleared system pairs a flexible nitinol implant with a deployable prong-locking mechanism, delivering rotational and length stability
Coal India has committed to providing upto Rs. 3 crore to treat thalassaemia and aplastic anaemia patients for a period of 3 years
Performed an autologous bone marrow transplant, using the patient’s own cells to reduce the chances of infection and rejection
With just few days of treatment, the patient started responding well and finally complete clinical resolution of infection was attained
Expanding to states like Maharashtra, Andhra Pradesh, Telangana, and Manipur while marking the significant milestone in its journey towards providing accessible healthcare services
It provides doctors with three indicators: identification of the bone, confirmation of device insertion into the bone, and notification in case of perforation through the opposite end of the bone
This supply agreement provides material for the company’s planned 30-patient pilot study, and later for its planned U.S. pivotal study in spine fusion patients
Subscribe To Our Newsletter & Stay Updated